Back

Long-term effect of beta-blockers after myocardial infarction with preserved left ventricular ejection fraction in a per protocol analysis of the REDUCE-AMI trial

28 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Contemporary pharmacotherapy after acute coronary syndromes: beta-blockers, lipids, and platelet inhibition Beta-Blockers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Tomas Jernberg

Karolinska Institute, Stockholm (Sweden)

7 More presentations in this session

Presentation thumbnail
Effect of beta-blockers on cardiovascular hospitalisation after myocardial infarction: A substudy of the BETAMI-DANBLOCK trial.
Doctor H. Caglar (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Troponin-stratified outcomes of extended clopidogrel monotherapy versus dual antiplatelet therapy in acute coronary syndrome: insights from the OPT-BIRISK randomized trial
Professor M. Qiu (Shenyang, CN)
Abstract Slides
Presentation thumbnail
Coordinated post-myocardial infarction care versus the PCSK9 modulator drug program: a comparative outcomes study
Professor M. Banach (Lodz, PL)
Abstract Slides
Presentation thumbnail
Long-term clinical outcomes of beta-blocker therapy in elderly patients with preserved left ventricular function after percutaneous coronary intervention for acute myocardial infarction
Assistant Professor J. Choe (Pusan, KR)
Abstract Slides
Presentation thumbnail
Impact of stepwise dual antiplatelet therapy de-escalation in patients with high bleeding risk undergoing drug-coated balloon angioplasty: Insights from the REC-CAGEFREE II trial
Associate Professor C. Gao (Hefei, CN)

Access the full session

Session thumbnail
Contemporary pharmacotherapy after acute coronary syndromes: beta-blockers, lipids, and platelet inhibition

The Event

Event poster

ESC Congress 2026

28 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic impact of beta-blockers in AMI patients with mid-range left ventricular ejection fraction
21 May 2023
thumbnail
Congress Presentation
Effects of Beta-Blockers on Quality of Life and Well-being in Patients with Myocardial Infarction and Preserved Left Ventricular Function - a prespecified substudy from REDUCE-AMI
1 September 2024
thumbnail
Congress Presentation
Statin therapy in chronic heart failure with reduced ejection fraction: a post-hoc analysis of T.O.S.C.A. Registry
3 April 2025
thumbnail
Congress Presentation
History of betablocker treatment breaks and risk of ventricular tachyarrhythmias among patients with heart failure and implantable cardioverter defibrillator: a nationwide cohort study
29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources